11:10 AM EDT, 08/30/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts edged lower late Friday morning, nudging down 0.03% to 1,476.31 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and furniture maker Natuzzi (NTZ), which climbed 7.1% and 5.5%, respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and internet advertising firm Criteo ( CRTO ) , which rose 3.3% and 2.7%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and petroleum refiner Equinor ( EQNR ) , which fell 5.1% and 2.5%, respectively. They were followed by hotel booking site trivago (TRVG) and telecommunications operator Nokia ( NOK ) , which were down 1.5% and 1.2%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma ( VRNA ) and TC Biopharm ( TCBP ) , which rose 3.3% and 3%, respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Amarin ( AMRN ) , which were up 1.5% and 1.3%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) , which plunged 52%, followed by Trinity Biotech ( TRIB ) and pharmaceutical company Silence Therapeutics ( SLN ) , which fell 3.5% and 2.2%, respectively, while oil and gas company Shell (SHEL) dropped 1.9%.